**Abstract**

Objective: Humans and many animals including non-human primates organize and live in social groups. Although dopamine (DA) has been suggested to play important roles in mediating social behavior, it has remained less clear whether and how DA in each subject consisting of a social group is involved in organization of such a group as social hierarchy and affiliative relationships. In this study, we examined the impacts DA D1 receptor signaling on social relationships of socially housing non-human primates. Methods: The effects of D1 antagonist administration was examined using a group of Japanese macaques consisting of 4 males and 2 females, 3 years old. Chronic administration of D1 receptor antagonist, SCH23390 (\~0.1 mg/kg/day) by subcutaneous implantation of an osmotic pump was given to the macaque at second rank in the group, which caused persist decrease of goal-directed actions and increased non-directional agonistic displays in the drug administered subject throughout the behavioral observation period for 1 month. Results: Although social dominance of the drug administered subject was not altered by drug administration, social dominance and affiliative relationships of other subjects in the groups, especially at higher social class, were altered, consequently resulting in stronger social order competitions among higher social class subjects including the drug administered one. However, chronic stress level of subjects, which were assessed by measuring the amount of hair glucocorticoids, were not altered in the drug administered subject as well as others, suggesting little negative consequence of re-organization of social relationships in the group. Conclusions: These results suggest that low D1 receptor signaling, which has been shown to cause detrimental effects on cognitive and affective function, may contradictorily not cause apparent disadvantages in animals such as non-human primates living in ecologically more natural socially groups.
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